We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Famotidine Shows More Promise for Hospitalized COVID-19 Patients
Famotidine Shows More Promise for Hospitalized COVID-19 Patients
A second study evaluating the use of the popular heartburn drug famotidine in patients with severe COVID-19 has found that the treatment reduced deaths and the need for intubation.